Please ensure Javascript is enabled for purposes of website accessibility
> 제품 > 항체 > 바이오시밀러

Research Grade Anti-Human CD274/PD-L1/B7-H1 (PDL-GEX) (HV974306)

Research Grade Anti-Human CD274/PD-L1/B7-H1 (PDL-GEX)
Research Grade Anti-Human CD274/PD-L1/B7-H1 (PDL-GEX)
가격(USD): $
사양:
  • 100ug
  • 1mg
수량:
문의하기
  • 개요

  • 이미지

  • 참고 문헌

  • 데이터시트

개요
카탈로그 번호HV974306
설명
Anti-Human CD274/PD-L1/B7-H1 (PDL-GEX) (HV974306) is a research-grade recombinant antibody targeting CD1. Produced in mammalian cells with native-like glycosylation.
Highlights
  • Research Grade — For PK/PD studies, assay development, and ADA research.
  • Native Glycosylation — Mammalian expression ensures native-like patterns.
종 반응성Human
응용 분야ELISA, Bioactivity: FACS, Functional assay, Research in vivo
숙주 종Human
이소타입IgG
클론 IDPDL-GEX
발현 시스템 Mammalian Cells
클론성 Monoclonal
타겟 B7-H1, Programmed cell death 1 ligand 1, PDCD1 ligand 1, PDCD1L1, B7 homolog 1, PDCD1LG1, PDL1, hPD-L1, Programmed death ligand 1, B7H1, PD-L1, CD274
내독소 수준 Please contact the lab for this information.
순도 >95% purity as determined by SDS-PAGE.
정제 Protein A/G purified from cell culture supernatant.
등록번호 Q9NZQ7
형태 Liquid
저장 완충액 0.01M PBS, pH 7.4.

데이터시트 인쇄본 또는 로트별 COA에 기재된 구체적인 완충액 정보를 참조하세요.

안정성 및 저장 Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
대체 이름PDL-GEX, PDLGEX, PDLGEX
배경

Programmed cell death 1 ligand 1 (CD274/PD-L1) is a ~33 kDa protein. Plays a critical role in induction and maintenance of immune tolerance to self. As a ligand for the inhibitory receptor PDCD1/PD-1, modulates the activation threshold of T-cells and limits T-cell effector response. Through a yet unknown activating receptor, may costimulate T-cell subsets that predominantly produce interleukin-10 (IL10). Can also act as a transcription coactivator: in response to hypoxia, translocates into the nucleus via its interaction with phosphorylated STAT3 and promotes transcription of GSDMC, leading to pyroptosis. CD274 is the therapeutic target of atezolizumab (Tecentriq) and durvalumab (Imfinzi).

1. Freeman, GJ. et al. (2000) The Journal of experimental medicine 192, 1027-34. PMID: 11015443
2. Mezzadra, R. et al. (2017) Nature 549, 106-110. PMID: 28813410
3. Burr, ML. et al. (2017) Nature 549, 101-105. PMID: 28813417
4. Huang, X. et al. (2019) Cancer immunology research 7, 1580-1590. PMID: 31399419
5. Kennedy, A. et al. (2023) The EMBO journal 42, e111556. PMID: 36727298
6. Dong, H. et al. (1999) Nature medicine 5, 1365-9. PMID: 10581077
7. Hou, J. et al. (2020) Nature cell biology 22, 1264-1275. PMID: 32929201
참고사항 For research use only. Not suitable for clinical or therapeutic use.
이미지
  • Research Grade Anti-Human CD274/PD-L1/B7-H1 (PDL-GEX)

    SDS-PAGE

    SDS-PAGE for Research Grade Anti-Human CD274/PD-L1/B7-H1 (PDL-GEX)

참고 문헌
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
추천

문의하기 맞춤형 견적, 대량 주문 및 기타 문의 사항은

메일: support@abinScience.com

배급사 목록